BIOMAT Database Logo BIOMAT Database Logo

CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy. 2010

Jason F Okulicz, and Greg A Grandits, and Amy C Weintrob, and Michael L Landrum, and Anuradha Ganesan, and Nancy F Crum-Cianflone, and Brian K Agan, and Vincent C Marconi
Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, National Naval Medical Center, Bethesda, Maryland, USA. Jason.okulicz@amedd.army.mil

Sixty-two human immunodeficiency virus (HIV) controllers (6 elite and 56 viremic controllers) in the US Military Department of Defense HIV Natural History Study cohort initiated highly active antiretroviral therapy (HAART) and achieved statistically significant mean CD4 cell count increases, although the gains were lower than those in treated noncontrollers. HIV controllers experienced CD4 cell count reconstitution with HAART regardless of pretherapy viral load, including patients with undetectable viral loads at HAART initiation.

UI MeSH Term Description Entries
D008297 Male Males
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults
D018791 CD4 Lymphocyte Count The number of CD4-POSITIVE T-LYMPHOCYTES per unit volume of BLOOD. Determination requires the use of a fluorescence-activated flow cytometer. Lymphocyte Count, CD4,T4 Lymphocyte Count,CD4 Cell Counts,CD4 Counts,CD4+ Cell Counts,CD4+ Counts,CD4 Cell Count,CD4 Count,CD4 Lymphocyte Counts,CD4+ Cell Count,CD4+ Count,Count, T4 Lymphocyte,Counts, T4 Lymphocyte,Lymphocyte Count, T4,Lymphocyte Counts, CD4,Lymphocyte Counts, T4,T4 Lymphocyte Counts
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Jason F Okulicz, and Greg A Grandits, and Amy C Weintrob, and Michael L Landrum, and Anuradha Ganesan, and Nancy F Crum-Cianflone, and Brian K Agan, and Vincent C Marconi
Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count.
June 2004, Journal of acquired immune deficiency syndromes (1999),
Jason F Okulicz, and Greg A Grandits, and Amy C Weintrob, and Michael L Landrum, and Anuradha Ganesan, and Nancy F Crum-Cianflone, and Brian K Agan, and Vincent C Marconi
Reconstitution of CD4 T cells in bronchoalveolar lavage fluid after initiation of highly active antiretroviral therapy.
September 2010, Journal of virology,
Jason F Okulicz, and Greg A Grandits, and Amy C Weintrob, and Michael L Landrum, and Anuradha Ganesan, and Nancy F Crum-Cianflone, and Brian K Agan, and Vincent C Marconi
Effects of highly active antiretroviral therapy on thymical reconstitution of CD4 T lymphocytes in vertically HIV-infected children.
May 2002, AIDS (London, England),
Jason F Okulicz, and Greg A Grandits, and Amy C Weintrob, and Michael L Landrum, and Anuradha Ganesan, and Nancy F Crum-Cianflone, and Brian K Agan, and Vincent C Marconi
CD4-cell count changes after treatment initiation in HIV controllers.
June 2010, Journal watch. AIDS clinical care,
Jason F Okulicz, and Greg A Grandits, and Amy C Weintrob, and Michael L Landrum, and Anuradha Ganesan, and Nancy F Crum-Cianflone, and Brian K Agan, and Vincent C Marconi
Peripheral blood natural killer cell reconstitution after highly active antiretroviral therapy.
March 2000, AIDS (London, England),
Jason F Okulicz, and Greg A Grandits, and Amy C Weintrob, and Michael L Landrum, and Anuradha Ganesan, and Nancy F Crum-Cianflone, and Brian K Agan, and Vincent C Marconi
Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.
August 2006, AIDS (London, England),
Jason F Okulicz, and Greg A Grandits, and Amy C Weintrob, and Michael L Landrum, and Anuradha Ganesan, and Nancy F Crum-Cianflone, and Brian K Agan, and Vincent C Marconi
Evidence of thymic reconstitution after highly active antiretroviral therapy in HIV-1 infection.
March 2004, HIV medicine,
Jason F Okulicz, and Greg A Grandits, and Amy C Weintrob, and Michael L Landrum, and Anuradha Ganesan, and Nancy F Crum-Cianflone, and Brian K Agan, and Vincent C Marconi
Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
August 2005, Journal of immunology (Baltimore, Md. : 1950),
Jason F Okulicz, and Greg A Grandits, and Amy C Weintrob, and Michael L Landrum, and Anuradha Ganesan, and Nancy F Crum-Cianflone, and Brian K Agan, and Vincent C Marconi
Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy.
July 1998, Nature medicine,
Jason F Okulicz, and Greg A Grandits, and Amy C Weintrob, and Michael L Landrum, and Anuradha Ganesan, and Nancy F Crum-Cianflone, and Brian K Agan, and Vincent C Marconi
Vitamin-D deficiency impairs CD4+T-cell count recovery rate in HIV-positive adults on highly active antiretroviral therapy: A longitudinal study.
October 2016, Clinical nutrition (Edinburgh, Scotland),
Copied contents to your clipboard!